Xiaoping Chen

19PUBLICATIONS
44CO-AUTHORS
Genome structure and regulationApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Sep 18, 2026
In vivo CRISPR screens identify the glutamine transporter SLC1A5 as a metabolic barrier to antitumor immunity.

|Sep 07, 2026
B cells in cancer: functions, mechanisms and therapeutic advances.

|Jun 30, 2026
Advances and prospects in cell therapy for cancer: explorations from T cells to stem cells.

|Mar 17, 2026
The multifaceted roles of the ACSL family in cancer: Metabolic reprogramming, ferroptosis regulation and tumour immune microenvironment remodelling.

Haocai Li, Weijian Wang, Juncheng Zhan

|Oct 10, 2025
VRK2 targeting potentiates anti-PD-1 immunotherapy in hepatocellular carcinoma through MYC destabilization.

Chen Su, Zhibin Liao, Jie Mo

|Apr 26, 2025
m6A-Mediated TMCO3 Promotes Hepatocellular Carcinoma Progression by Facilitating the Membrane Translocation and Activation of AKT.

Xinxin Li, Mengzhen Han, He Zhu

Pageof 4

Frequent Collaborators

4 joint publications

Bixiang Zhang

4 joint publications

Huifang Liang

4 joint publications

Bixiang Zhang

3 joint publications

Wanguang Zhang